News for 'Dr Reddy'

'Unsung heroes': BCCI's bonanza for IPL's ground staff

'Unsung heroes': BCCI's bonanza for IPL's ground staff

Rediff.com27 May 2024

The ground staff and curators of all the 10 regular IPL venues will be given Rs 25 lakh each.

Covid resurgence makes investors jittery; Sensex tanks 397 pts

Covid resurgence makes investors jittery; Sensex tanks 397 pts

Rediff.com15 Mar 2021

Bajaj Finserv was the top loser in the Sensex pack, shedding around 3 per cent, followed by Bajaj Auto, Bajaj Finance, L&T, Asian Paints, Dr Reddy's, ICICI Bank, HDFC Bank and RIL. NSE Nifty finished 101.45 points down at 14,929.50.

Sensex, Nifty end marginally up on fag-end buying

Sensex, Nifty end marginally up on fag-end buying

Rediff.com28 Jun 2022

Equity benchmark indices halted their three-day gain on Tuesday, with the Sensex falling over 317 points in early trade, amid weak global market trends and persistent foreign fund outflows. Firm crude oil prices in the international market also put pressure on equities. The 30-share BSE Sensex was trading 317.41 points lower at 52,843.87. The NSE Nifty dipped 99.65 points to 15,732.40.

Markets rebound over 2%; Sensex spurts 1,277 points

Markets rebound over 2%; Sensex spurts 1,277 points

Rediff.com4 Oct 2022

Benchmark indices Sensex and Nifty bounced back on Tuesday to close over 2 per cent higher amid positive trends in global equity markets. The 30-share BSE Sensex spurted 1,276.66 points or 2.25 per cent to settle at 58,065.47. During the day, it zoomed 1,311.13 points or 2.30 per cent to 58,099.94. The broader NSE Nifty rallied 386.95 points or 2.29 per cent to end at 17,274.30.

US drug shortage, stable pricing set to boost pharma revenues

US drug shortage, stable pricing set to boost pharma revenues

Rediff.com24 Jul 2023

An acute drug shortage in the US and stable pricing along with product launches are likely to boost revenues of India's pharmaceutical companies during the first quarter of this financial year, analysts said. Most brokerages estimate a top line growth of around 14-15 per cent, with earnings before interest, taxes, depreciation, and amortisation (Ebitda) growth of 24-30 per cent for Q1 of FY24. Hospitals are, however, likely to report lower occupancy rates, and diagnostics companies may witness an impact from delayed monsoon.

EC reveals electoral bond donors, but not who gave which party

EC reveals electoral bond donors, but not who gave which party

Rediff.com15 Mar 2024

From steel tycoon Lakshmi Mittal to billionaire Sunil Bharti Mittal's Airtel, Anil Agarwal's Vedanta, ITC, Mahindra and Mahindra, and a lesser-known Future Gaming and Hotel Services were among the prominent buyers of the now-scrapped electoral bonds for making political donations.

Sensex, Nifty close lower on selloff in power, metal stocks

Sensex, Nifty close lower on selloff in power, metal stocks

Rediff.com9 Nov 2022

Equity benchmarks Sensex and Nifty gave up early gains to close in the red on Wednesday after a selloff in power, metal and consumer durable stocks amid a weak trend in global equities. However, a rally in the rupee against the US dollar and unabated foreign capital inflows helped the indices restrict the losses, traders said. In a largely range-bound session, the 30-share BSE Sensex ended 151.60 points or 0.25 per cent lower at 61,033.55.

Markets end in red; Sensex tanks 461 points

Markets end in red; Sensex tanks 461 points

Rediff.com16 Dec 2022

Equity benchmarks Sensex and Nifty declined nearly 1 per cent on Friday, in tandem with a weak trend in overseas markets amid hawkish tone of global central banks. The 30-share BSE Sensex fell 461.22 points or 0.75 per cent to settle at 61,337.81. During the day, it tumbled 506.5 points or 0.81 per cent to 61,292.53.

Rouble fall to impact Indian pharma exports

Rouble fall to impact Indian pharma exports

Rediff.com17 Dec 2014

Russia's central bank early on Tuesday raised interest rates to 17 per cent to counter the 50 per cent rouble fall in six months.

Sensex soars past 52K; Nifty tops 15,300

Sensex soars past 52K; Nifty tops 15,300

Rediff.com15 Feb 2021

IndusInd Bank was the top gainer in the Sensex pack, rising around 2 per cent, followed by Axis Bank, HDFC, ICICI Bank, HDFC Bank, Kotak Bank and SBI. On the other hand, ONGC, Tech Mahindra, NTPC, Sun Pharma and TCS were among the laggards.

Markets fall for 6th session; Sensex dives 588 points

Markets fall for 6th session; Sensex dives 588 points

Rediff.com29 Jan 2021

Dr Reddy's, Maruti, Bharti Airtel, Bajaj Auto, Infosys, TCS and Bajaj FinServ were the major losers. On the other hand, IndusInd Bank, Sun Pharma, ICICI Bank and HDFC Bank ended with gains.

Sensex, Nifty settle at fresh lifetime highs

Sensex, Nifty settle at fresh lifetime highs

Rediff.com29 Nov 2022

The Sensex and Nifty ended at fresh lifetime peaks on Tuesday amid a largely firm trend in other Asian markets and continuous foreign fund inflows. The 30-share BSE Sensex gained 177.04 points or 0.28 per cent to settle at 62,681.84, its fresh record closing high. During the day, it jumped 382.6 points or 0.61 per cent to its lifetime intra-day peak of 62,887.40.

Markets fall sharply, Sensex tumbles 844 points

Markets fall sharply, Sensex tumbles 844 points

Rediff.com11 Oct 2022

Equity benchmark indices fell sharply on Tuesday, with the Sensex tumbling nearly 844 points, in line with weak global market trends and foreign fund outflows. The 30-share BSE benchmark slumped 843.79 points or 1.46 per cent to settle at 57,147.32. During the day, it tanked 940.71 points or 1.62 per cent to 57,050.40.

Sensex ends down 115 pts; closes FY22 with 18% gains

Sensex ends down 115 pts; closes FY22 with 18% gains

Rediff.com31 Mar 2022

Benchmark BSE Sensex gave up its early gains to settle lower by 115 points on the last day of 2021-22 fiscal on Thursday, dragged down by profit-taking in Reliance Industries, Infosys and HDFC Bank after a three-day rally. The 30-share barometer declined by 115.48 points or 0.20 per cent to settle at 58,568.51 in choppy trade due to the expiry of monthly derivatives contracts. During the day, it touched a high of 58,890.92 and a low of 58,485.79.

Samvat 2078 starts on auspicious note; BSE, NSE end in green

Samvat 2078 starts on auspicious note; BSE, NSE end in green

Rediff.com4 Nov 2021

M&M led the gainers' pack, spurting 2.76 per cent, followed by ITC, Kotak Bank, L&T, SBI, Bajaj Auto and Nestle India.

Electoral Bonds: The Quid Pro Quo Factor

Electoral Bonds: The Quid Pro Quo Factor

Rediff.com3 Apr 2024

Which entrepreneur would willingly part with her or his hard-earned money for grasping, self-serving politicians? asks Debashis Basu.

Markets tumble nearly 1%; Sensex tanks 509 points

Markets tumble nearly 1%; Sensex tanks 509 points

Rediff.com28 Sep 2022

Benchmark indices ended nearly 1 per cent lower on Wednesday, tracking a weak trend in global markets and continuous foreign fund outflows. The 30-share BSE Sensex fell 509.24 points or 0.89 per cent to settle at 56,598.28. During the day, it tanked 621.85 points or 1.08 per cent to 56,485.67. Similarly, the broader NSE Nifty declined 148.80 points or 0.87 per cent to end at 16,858.60.

Sensex climbs 465 points; Nifty ends above 17,500

Sensex climbs 465 points; Nifty ends above 17,500

Rediff.com8 Aug 2022

The 30-share BSE gauge climbed 465.14 points or 0.80 per cent to finish at 58,853.07. During the day, it jumped 546.97 points or 0.93 per cent to 58,934.90.

Ranji: Sindhu's 11-wkt haul powers Haryana to victory

Ranji: Sindhu's 11-wkt haul powers Haryana to victory

Rediff.com8 Nov 2024

Punjab, starting the penultimate day on 73/3 and needing 144 more runs, crumbled under pressure from Sindhu's relentless spin and Jayant Yadav's precise off-spin (3/35 in 10.4 overs), collapsing well before lunch and handing Haryana their second outright win in four matches.

Shah's doctored video: 12 more summoned; AAP, Cong men held in Gujarat

Shah's doctored video: 12 more summoned; AAP, Cong men held in Gujarat

Rediff.com30 Apr 2024

In total, 17 people, including Telangana Chief Minister and Congress leader Revanth Reddy, have been issued notices to appear before the Delhi police's investigation officer (in connection with the case. Sources, however, said Reddy is "unlikely" to join the probe and may send his representative.

After 8 days, investors book profit; Sensex ends down 416 points

After 8 days, investors book profit; Sensex ends down 416 points

Rediff.com2 Dec 2022

Equity benchmark indices ended lower on Friday, halting their eight-day rally, amid a weak trend in global markets and emergence of profit-taking. The 30-share BSE Sensex fell 415.69 points or 0.66 per cent to settle at 62,868.50. During the day, it tanked 604.56 points or 0.95 per cent to 62,679.63.

Markets halt 7-day rally; RIL, finance stocks weigh

Markets halt 7-day rally; RIL, finance stocks weigh

Rediff.com25 Oct 2022

Equity benchmarks ended lower on Tuesday, putting a break to their seven-day rally, amid weak Asian market cues and mixed trends from European stocks. The 30-share BSE benchmark failed to hold on the early gains and declined 287.70 points or 0.48 per cent to finish at 59,543.96. During the day, it hit a low of 59,489.02 and a high of 60,081.24.

Bank stocks drag Sensex 441 points lower; Nifty slips below 15K-level

Bank stocks drag Sensex 441 points lower; Nifty slips below 15K-level

Rediff.com5 Mar 2021

On the Sensex chart, IndusInd Bank, SBI, Dr Reddy's, NTPC, ICICI Bank, HCL Tech and Bajaj FinServ emerged as major laggards.

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Q3 result preview: US, India to aid revenue growth for Pharma Inc

Rediff.com30 Jan 2024

The pharmaceuticals sector is expected to post a revenue growth of around 13.5 per cent and a net profit growth of 30.3 per cent for the third quarter of 2023-24 (FY24), riding on the approval for niche drugs in the US market, fall in raw material prices and correction in shipping rates. In the healthcare segment, hospitals are expected to post revenue growth of 13 per cent during the coverage, while net profit growth would be around 37 per cent, ICICI Securities said in a note. However, the performance may not be comparable on a sequential basis due to the offset of the festive season in Q3FY24, the analysts noted.

Financial, pharma stocks give Sensex a 359-point boost

Financial, pharma stocks give Sensex a 359-point boost

Rediff.com10 Jun 2021

On the Sensex chart, Bajaj Finance, Bajaj FinServ, SBI, IndusInd Bank, Dr Reddy's, Tech Mahindra, ITC and Kotak Bank were the prominent gainers - rising up to 7.29 per cent. NSE Nifty climbed 102.40 points to end at 15,737.75.

Is India Witnessing a Second Surge of COVID-19?

Is India Witnessing a Second Surge of COVID-19?

Rediff.com27 Jul 2020

'Both the governments and people have to recognise that this is a long race, not a short sprint.'

Patidar Gets His Test Cap From Zaheer!

Patidar Gets His Test Cap From Zaheer!

Rediff.com2 Feb 2024

Rajat Patidar becomes India's 310th Test player.

Sensex snaps 4-day losing streak; ends up428 points

Sensex snaps 4-day losing streak; ends up428 points

Rediff.com9 Jun 2022

Powered by a rally in index heavyweight Reliance Industries, equity benchmark Sensex broke its four-session losing run to close above the 55,000-mark on Thursday despite a weak trend overseas. Investors made a cautious return to IT, pharma and bank stocks after their recent sell-off. However, a depreciating rupee and persistent foreign fund outflows capped the gains, traders said. Overcoming a lacklustre start, the 30-share BSE Sensex surged 427.79 points or 0.78 per cent to close at 55,320.28.

Sensex drops 132 pts after RBI policy; banking stocks drag

Sensex drops 132 pts after RBI policy; banking stocks drag

Rediff.com4 Jun 2021

Nestle India was the top laggard in the Sensex pack, shedding around 2 per cent, followed by SBI, HDFC Bank, Axis Bank, ICICI Bank, Reliance Industries, HUL and Dr Reddy's. NSE Nifty slipped 20.10 points to 15,670.25.

PM holds meet with teams involved in developing COVID vaccine

PM holds meet with teams involved in developing COVID vaccine

Rediff.com30 Nov 2020

The teams were from Gennova Biopharmaceuticals Ltd Pune, Biological E Ltd Hyderabad and Dr Reddys Laboratories Ltd Hyderabad.

Markets extend rally to 3rd day; Sensex climbs over 300 points

Markets extend rally to 3rd day; Sensex climbs over 300 points

Rediff.com8 Jul 2022

Benchmark indices gained for the third day running on Friday, with the Sensex climbing over 300 points amid mixed global market trends. The 30-share BSE benchmark advanced 303.38 points or 0.56 per cent to settle at 54,481.84. During the day, it jumped 448.68 points or 0.82 per cent to 54,627.14. The broader NSE Nifty went higher by 87.70 points or 0.54 per cent to end at 16,220.60.

Hasina in shock, govt giving her time: Jaishankar

Hasina in shock, govt giving her time: Jaishankar

Rediff.com6 Aug 2024

Jaishankar briefed the leaders of all parties about the situation in the violence-hit nation and the steps taken by the Indian government.

Sensex rallies 458 pts to end above 50K for first time; Nifty tops 14,750

Sensex rallies 458 pts to end above 50K for first time; Nifty tops 14,750

Rediff.com3 Feb 2021

IndusInd Bank was the top gainer in the Sensex pack, zooming around 8 per cent, followed by PowerGrid, Dr Reddy's, Sun Pharma, NTPC and Axis Bank. On the other hand, UltraTech Cement, Maruti, ITC, Kotak Bank and Asian Paints were among the losers.

DRDO's Covid drug: Benefits. Concerns

DRDO's Covid drug: Benefits. Concerns

Rediff.com31 May 2021

Commercial launch and supply to major government and private hospitals is expected in mid-June.

Covid vaccine could cost up to Rs 1000 in private market

Covid vaccine could cost up to Rs 1000 in private market

Rediff.com28 Apr 2021

While the Indian government has been procuring Covid-19 vaccines at low prices so far, manufacturers have to declare the prices of vaccines they would supply to the open market (industries, private hospitals, etc) and state governments before May 1. Sohini Das reports.

After gyrating over 721 points, Sensex ends in red

After gyrating over 721 points, Sensex ends in red

Rediff.com13 Jan 2021

M&M was the top gainer in the Sensex pack, rallying around 6 per cent, followed by SBI, ITC, NTPC, Bharti Airtel and ONGC. On the other hand, Bajaj Finance, HDFC, Bajaj Finserv, Titan, Sun Pharma and Dr Reddy's were among the laggards. NSE Nifty inched up 1.40 points to its fresh closing record of 14,564.85.

India witnessing fastest rise in cancer cases: Report

India witnessing fastest rise in cancer cases: Report

Rediff.com5 Apr 2024

On average, at least one in three Indians today were pre-diabetic, two in three were pre-hypertensive and one in 10 were depressed, the 4th edition of Apollo Hospitals' flagship Health of Nation Report on World Health Day 2024, said.

'Only A Very Rich Man Can Stand For Elections'

'Only A Very Rich Man Can Stand For Elections'

Rediff.com8 May 2024

'All my wealth I earned in the US. It is all money earned transparently. I have paid all taxes.'

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Merck to license oral Covid drug Molnupiravir to 5 Indian firms

Rediff.com27 Apr 2021

Drug firm MSD has decided to enter into voluntary licensing agreements for investigational oral antiviral drug candidate 'Mmolnupiravir', which is being studied for the treatment of Covid-19, with Indian drug firms Sun Pharma, Cipla, Dr Reddy's, Emcure Pharma and Hetero Labs, its Indian arm said on Tuesday.

Electoral bonds: Who is lottery king Santiago Martin?

Electoral bonds: Who is lottery king Santiago Martin?

Rediff.com15 Mar 2024

Future Gaming and Hotel Services whose director is the lottery magnate Santiago Martin is the top purchaser of electoral bonds having purchased bonds worth Rs 1,368, according to data uploaded by the Election Commission of India on its website on Thursday.